Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Merck
Colorcon
Harvard Business School
Mallinckrodt

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for GW842166

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug GW842166?

GW842166 is an investigational drug.

There have been 6 clinical trials for GW842166. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2007.

The most common disease conditions in clinical trials are Osteoarthritis, Inflammation, and Osteoarthritis, Knee. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].

Recent Clinical Trials for GW842166
TitleSponsorPhase
Dose Response and Efficacy of GW842166 in PainGlaxoSmithKlinePhase 1
Relative Bioavailability Study on a Single Dose of GW842166X in Healthy Male and Female Subjects.GlaxoSmithKlinePhase 1
A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With OsteoarthritisGlaxoSmithKlinePhase 2

See all GW842166 clinical trials

Clinical Trial Summary for GW842166

Top disease conditions for GW842166
Top clinical trial sponsors for GW842166

See all GW842166 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Medtronic
Mallinckrodt
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.